Loading...
XMEX
FRAGUAB
Market cap2.70bUSD
Aug 03, Last price  
477.56MXN
1D
2.51%
1Q
-0.62%
Jan 2017
83.14%
Name

Corporativo Fragua SAB de CV

Chart & performance

D1W1MN
XMEX:FRAGUAB chart
P/E
9.76
P/S
0.35
EPS
48.95
Div yield, %
2.92%
Shrs. gr., 5y
—
Rev. gr., 5y
12.50%
Revenues
132.12b
+9.88%
11,600,812,00014,575,199,00016,751,706,00019,146,767,00021,152,278,00023,237,265,00026,382,740,00028,955,200,00032,032,590,00035,790,002,00040,572,072,00046,673,744,00053,351,739,00061,884,200,00073,313,615,00084,794,429,00097,917,676,000109,374,181,000120,237,944,000132,118,539,000
Net income
4.69b
-4.39%
532,388,000672,074,000647,266,000609,333,000730,913,000848,560,000908,790,000963,193,000971,858,000973,567,0001,101,745,0001,343,092,0001,532,322,0001,709,995,0002,030,088,0002,621,797,0003,178,718,0004,500,600,0004,902,005,0004,686,936,000
CFO
4.09b
-12.16%
436,832,000309,229,000580,125,0001,273,625,0001,317,475,000928,658,0001,192,939,0001,086,348,0001,320,515,0002,079,544,0001,980,812,0001,723,572,0001,465,264,0002,856,981,0004,342,537,0004,268,502,0008,377,909,0006,370,933,0004,658,557,0004,091,877,000
Dividend
Mar 30, 202614.3 MXN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Corporativo Fragua, S.A.B. de C.V. oversees a chain of Superfarmacia drugstores located throughout Mexico. These retail outlets provide a wide array of products, including medicines, perfumes, photography supplies, household goods, and diverse food items such as fresh produce, baked goods, and deli meats. Furthermore, the company engages in the processing and sale of photographic apparatus and offers freight services. Established in 1942, Corporativo Fragua, S.A.B. de C.V. has its main office situated in Guadalajara, Mexico.
URL
https://www.farmaciasguadalajara.com.mx/
IPO date
Oct 03, 1997
Employees
Domiciled in
MX
Incorporated in
MX

Valuation

Title
MXN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT